Novel Bone-targeted Agents for Treatment of Osteoporosis

被引：0
|
作者：
Jun Bo WANG
机构：
来源：
Chinese Chemical Letters | 2005年 / 07期
关键词：
Osteoporosis; bone-targeted; raloxifene; bisphosphonate;
D O I：
暂无
中图分类号：
R58 [内分泌腺疾病及代谢病];
学科分类号：
摘要：
The novel bone-targeted agents were designed and synthesized by the combination of raloxifene and bisphosphonates. The anti-osteoporosis effect was evaluated by bone mineral density (BMD) obtained from OVX mice in vivo. The results indicated that the compound 8, 9 not only prevented ovariectomy induced loss of bone but also enhanced BMD to 0.87% and 19.67% compared to Sham, respectively.
引用
收藏
页码：859 / 862
页数：4
相关论文
共 50 条
  • [41] Novel Agents in the Treatment of Osteoporosis
    Shuid, Ahmad Nazrun
    Soelaiman, Ima Nirwana
    Das, Srijit
    CURRENT DRUG TARGETS, 2013, 14 (14) : 1631 - 1631
  • [42] Bone-targeted ultrasound-responsive nanobubbles for siRNA delivery to treat osteoporosis in mice
    Sotoudehbagha, Pedram
    Flores, Abel Cordova
    Hartmann, Thomas
    Pattilachan, Tara
    Razavi, Mehdi
    BIOMATERIALS ADVANCES, 2025, 166
  • [43] Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology
    Fusco, Vittorio
    Santini, Daniele
    Armento, Grazia
    Tonini, Giuseppe
    Campisi, Giuseppina
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (07) : 925 - 935
  • [44] Perspectives on bone-targeted nano-drug carriers for bone tumor treatment
    LIU Ping
    WANG Jian
    中国药理学与毒理学杂志, 2016, (10) : 1074 - 1075
  • [45] Guideline adherence in bone-targeted treatment of cancer patients with bone metastases in Germany
    Link, Hartmut
    Diel, Ingo
    Ohlmann, Carsten-H
    Holtmann, Laura
    Kerkmann, Markus
    SUPPORTIVE CARE IN CANCER, 2020, 28 (05) : 2175 - 2184
  • [46] Effects of bone-targeted nanoparticles on bone metastasis
    Salerno, M.
    Fotia, C.
    Avnet, S.
    Cenni, E.
    Granchi, D.
    Castelli, F.
    Micieli, D.
    Pignatello, R.
    Rucci, N.
    Teti, A.
    Giunti, A.
    Baldini, N.
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S91 - S91
  • [47] Facile fabrication of phosphazene-quercetin-alendronate composites as pH-responsive bone-targeted nanomedicine for osteoporosis treatment
    Yang, Xiaowei
    Lai, Qi
    Guo, Jingchong
    Yang, Xinmin
    Zhu, Weifeng
    Zhou, Song
    Liu, Meiying
    Zhang, Xiaoyong
    Zhang, Bin
    Wei, Yen
    MATERIALS & DESIGN, 2024, 241
  • [48] Evaluating the impact of bone-targeted agents in the era of novel androgen targeted therapy for metastatic castration-resistant prostate cancer.
    Li, Haoran
    Kamel, Dalia
    Fernandes, Ricardo
    Bosse, Dominick
    Vo, Dong
    Souied, Osama
    Kumar, Vikaash
    Ong, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [49] Novel one-pot strategy for fabrication of a pH-Responsive bone-targeted drug self-frame delivery system for treatment of osteoporosis
    Yang, Xinmin
    Yang, Xiaowei
    Luo, Peng
    Zhong, Yanlong
    Zhang, Bin
    Zhu, Weifeng
    Liu, Meiying
    Zhang, Xiaoyong
    Lai, Qi
    Wei, Yen
    MATERIALS TODAY BIO, 2023, 20
  • [50] Novel bone-targeted Src tyrosine kinase inhibitor drug discovery
    Shakespeare, WC
    Metcalf, CA
    Wang, YH
    Sundaramoorthi, R
    Keenan, T
    Weigele, M
    Bohacek, RS
    Dalgarno, DC
    Sawyer, TK
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2003, 6 (05) : 729 - 741
12345